These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 7310012)

  • 21. Lack of effect of lodoxamide and verapamil on antimicrobial action in vitro.
    McGregor JA; Levin MJ; Masters H
    J Infect Dis; 1986 Sep; 154(3):542-3. PubMed ID: 3734496
    [No Abstract]   [Full Text] [Related]  

  • 22. Efficacy of lodoxamide eye drops on tear fluid cytology of patients with vernal conjunctivitis.
    Oguz H; Bitiren M; Aslan OS; Ozardali I
    Acta Med Okayama; 1999 Jun; 53(3):123-6. PubMed ID: 10410789
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antiallergic activity of topical lodoxamide on in vivo and in vitro models.
    Ciprandi G; Buscaglia S; Catrullo A; Paolieri F; Riccio AM; Fiorino N; Canonica GW
    Allergy; 1996 Dec; 51(12):946-51. PubMed ID: 9020426
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addition of a mast cell stabilizing compound to organ preservation solutions decreases lung reperfusion injury.
    Barr ML; Carey JN; Nishanian GP; Roberts RF; Sakamaki Y; Darbinian SH; Starnes VA
    J Thorac Cardiovasc Surg; 1998 Mar; 115(3):631-6; discussion 636-7. PubMed ID: 9535451
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hepatic microvascular regulatory mechanisms. IV. Effect of lodoxamide tromethamine and arterenol-HCl on vascular responses evoked by compound 48/80.
    Reilly FD; Dimlich RV
    Microcirc Endothelium Lymphatics; 1984 Feb; 1(1):87-106. PubMed ID: 6152810
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of common ocular allergic disorders; a comparison of lodoxamide and NAAGA.
    Denis D; Bloch-Michel E; Verin P; Sebastiani A; Tazartes M; Helleboid L; Di Giovanni A; Lecorvec M
    Br J Ophthalmol; 1998 Oct; 82(10):1135-8. PubMed ID: 9924299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Hepatic microvascular regulatory mechanisms. V. Effects of lodoxamide tromethamine or phentolamine-HCl on vascular responses elicited by serotonin.
    Reilly FD; Cilento EV; McCuskey RS
    Microcirc Endothelium Lymphatics; 1984 Dec; 1(6):671-89. PubMed ID: 6100792
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of exercise-induced bronchospasm by atropine.
    Tinkelman DG; Cavanaugh MJ; Cooper DM
    Am Rev Respir Dis; 1976 Jul; 114(1):87-94. PubMed ID: 779554
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Lodoxamide in vernal keratoconjunctivitis.
    Lee S; Allard TR
    Ann Pharmacother; 1996 May; 30(5):535-7. PubMed ID: 8740338
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The effect of cromolyn sodium on exercise-induced bronchospasm using a free running system.
    Shapiro GG; Pierson WE; Bierman CW
    Pediatrics; 1975 Nov; 56(5 pt-2 suppl):923-6. PubMed ID: 810765
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Alomide, a preventive immunopharmaceutical agent, in the treatment of ocular atopy].
    Krásný J
    Cesk Slov Oftalmol; 1998 Jan; 54(1):41-5. PubMed ID: 9501643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Determination of lodoxamide in plasma using ion-pairing and reversed-phase high-performance liquid chromatography.
    Honigberg IL; Stewart JT; Ewing BJ; Taylor WD
    J Chromatogr; 1983 Aug; 276(1):213-7. PubMed ID: 6672016
    [No Abstract]   [Full Text] [Related]  

  • 33. Double-blind, cross-over study of cromolyn sodium inhibition of exercise-induced bronchospasm in adults.
    Wallace D; Grieco MH
    Ann Allergy; 1976 Sep; 37(3):153-63. PubMed ID: 822760
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Hepatic microvascular regulatory mechanisms. VI. Effects of lodoxamide tromethamine or phentolamine-HCl on early hemodynamic and glucoregulatory alterations evoked by endotoxin.
    Reilly FD; Dimlich RV
    Microcirc Endothelium Lymphatics; 1985 Jun; 2(3):271-92. PubMed ID: 3836345
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy of lodoxamide 0.1% versus N-acetyl aspartyl glutamic acid 6% ophthalmic solutions in patients with vernal keratoconjunctivitis.
    Gündüz K; Uçakhan O; Budak K; Eryilmaz T; Ozkan M
    Ophthalmic Res; 1996; 28(2):80-7. PubMed ID: 8792357
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of oxidative enzymes by anti-allergy drugs.
    White GJ
    Agents Actions; 1981 Nov; 11(5):503-9. PubMed ID: 6121476
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Contrast of the effect of alomide and sodium cromoglycate in the treatment of allergic eye diseases.
    Zhang W; Lin Z
    Yan Ke Xue Bao; 2000 Sep; 16(3):214-6. PubMed ID: 12579651
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Single dose of montelukast as an effective prevention of post exercise bronchospasm in children with bronchial asthma].
    Gaszczyk G; Latoś T; Słowikowski A; Janiak B
    Med Wieku Rozwoj; 2004; 8(3 Pt 2):847-56. PubMed ID: 15858257
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Antigen-induced neutrophil chemotactic activity in man. Correlation with bronchospasm and inhibition by disodium cromoglycate.
    Atkins PC; Norman ME; Zweiman B
    J Allergy Clin Immunol; 1978 Sep; 62(3):149-55. PubMed ID: 98551
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Randomised double-masked trial of lodoxamide and sodium cromoglycate in allergic eye disease. A multicentre study.
    Fahy GT; Easty DL; Collum LM; Benedict-Smith A; Hillery M; Parsons DG
    Eur J Ophthalmol; 1992; 2(3):144-9. PubMed ID: 1450659
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.